Abbott Laboratories (NYSE:ABT) shares, rose in value on Friday, November 01, with the stock price up by 5.15% to the previous day’s close as strong demand from buyers drove the stock to $119.21.
Actively observing the price movement in the recent trading, the stock is buoying the session at $113.37, falling within a range of $117.095 and $119.92. The value of beta (5-year monthly) is 0.722 whereas the PE ratio is 36.22 over 12-month period. Referring to stock’s 52-week performance, its high was $121.64, and the low was $92.43. On the whole, ABT has fluctuated by 6.22% over the past month.
With the market capitalization of Abbott Laboratories currently standing at about $207.41 billion, investors are eagerly awaiting this quarter’s results, scheduled for on 2025-Jan-22. The company’s Forward Dividend Ratio is 2.20, with its dividend yield at 1.85%.
Projections by analysts suggest varying estimates for the company’s quarterly revenue. Analysts have estimated the company’s revenue for the quarter at 42.01B, with a low estimate of 10.87B and a high estimate of 11.21B. Wall Street analysts also predicted that the company’s y-o-y revenues would reach 11.04B.
Technical indicators serve as essential tools for traders, offering insights into market sentiment and potential price movements. We see that ABT’s technical picture suggests that short-term indicators denote the stock is a 100% Buy on average. However, medium-term indicators have put the stock in the category of 100% Buy while long-term indicators on average have been pointing out that it is a 50% Buy.
The stock’s technical analysis shows that the PEG ratio is about 4.02, with the price of ABT currently trading nearly 2.79% and 3.72% away from the simple moving averages for 20 and 50 days respectively. The Relative Strength Index (RSI, 14) currently indicates a reading of 61.22, while the 7-day volatility ratio is showing 1.64% which for the 30-day chart, stands at 1.53%. Furthermore, Abbott Laboratories (ABT)’s beta value is 0.72, and its average true range (ATR) is 2.15.
A comparison of Abbott Laboratories (ABT) with its peers suggests the former has fared considerably weaker in the market. ABT showed an intraday change of 5.15% in today’s session so far, and over the past year, it grew by 25.47%%.
Data on historical trading for Abbott Laboratories (NYSE:ABT) indicates that the trading volumes over the past 10 days have averaged 5.3 and over the past 3 months, they’ve averaged 5.04 million. According to company’s latest data on outstanding shares, there are 1.73 billion shares outstanding.
Nearly 0.66% of Abbott Laboratories’s shares belong to company insiders and institutional investors own 76.93% of the company’s shares. The data on short interest also indicates that stock shorts accounted for 13.98 million shares as on 2024-10-15, resulting in a short ratio of 2.87. According to the data, the short interest in Abbott Laboratories (ABT) stood at 81.00 of shares outstanding as of 2024-10-15; the number of short shares registered in 2024-09-13 reached 13.36 million. The stock has risen by 8.30% since the beginning of the year, thereby showing the potential of a further growth. This could raise investors’ confidence to be optimistic about the ABT stock heading into the next quarter.
